+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cutaneous silent periods - Part 2: Update on pathophysiology and clinical utility



Cutaneous silent periods - Part 2: Update on pathophysiology and clinical utility



Clinical Neurophysiology 2019



Testing of exteroceptive electromyographic modulation of ongoing voluntary muscle activity is of increasing interest as a diagnostic tool in clinical neurophysiology. The cutaneous silent period (CSP) is a robust and reproducible nociceptive EMG suppression, mediated at the spinal level by small-diameter A-delta afferents. The techniques and physiological principles of CSP testing, which are a fundamental prerequisite for a valid and thoughtful clinical application, are reviewed separately in part 1 (Kofler et al., 2019). This comprehensive review surveys the literature on pathophysiological conditions in which CSPs have been reported, and aims at a critical overview on the clinical utility of CSP testing. The most useful clinical applications seem to be the functional diagnostics of intramedullary, in particular centromedullary, dysfunctions, and the assessment of small fiber neuropathies, in particular those affecting A-delta fibers. CSPs have in addition been studied in a variety of movement disorders and in neuropathic pain and other painful conditions, including fibromyalgia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446901

Download citation: RISBibTeXText

PMID: 30704842

DOI: 10.1016/j.clinph.2019.01.003


Related references

Cutaneous silent periods - Part 1: Update on physiological mechanisms. Clinical Neurophysiology 2019, 2019

Small fiber neuropathy associated with hyperlipidemia: utility of cutaneous silent periods and autonomic tests. Isrn Neurology 2014: 579242, 2014

Assessment of symptomatic diabetic patients with normal nerve conduction studies: utility of cutaneous silent periods and autonomic tests. Muscle and Nerve 43(3): 317-323, 2011

Cutaneous silent periods of the vastus medialis evoked by the stimulation of lateral femoral cutaneous nerve. Clinical Neurophysiology 116(6): 1335-1341, 2005

Cutaneous silent periods. Muscle and Nerve 28(4): 391-401, 2003

Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis. Actas Dermo-Sifiliograficas 107(1): 5-14, 2017

Influence of limb temperature on cutaneous silent periods. Clinical Neurophysiology 125(9): 1826-1833, 2015

Cutaneous silent periods in patients with Fabry disease. Muscle & Nerve 23(8): 1179-1186, August, 2000

Cutaneous and mixed nerve silent periods in syringomyelia. Clinical Neurophysiology 112(1): 78-85, January, 2001

Cutaneous silent periods in multiple system atrophy. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 159(2): 327-332, 2016

Cutaneous silent periods in intramedullary spinal cord lesions. Journal of the Neurological Sciences 216(1): 67-79, 2003

Preserved cutaneous silent periods in severe entrapment neuropathies. Muscle and Nerve 28(6): 711-714, 2003

Cutaneous silent periods are not affected by the antihistaminic drug cetirizine. Clinical Neurophysiology 120(5): 1016-1019, 2009

Cutaneous silent periods in the assessment of mild cervical spondylotic myelopathy. Spine 34(1): 34-42, 2009

Cutaneous silent periods in the evaluation of cord compression in cervical spondylosis. Journal of Neurology 254(1): 14-19, 2007